Skip to Content

Celvapan

Active Substance: whole virion, inactivated containing antigen: A/California/07/2009 (H1N1)v
Common Name: influenza vaccine (H1N1)v (whole virion, inactivated, prepared in cell culture)
ATC Code: J07BB01
Marketing Authorisation Holder: Nanotherapeutics Bohumil, s.r.o.
Active Substance: whole virion, inactivated containing antigen: A/California/07/2009 (H1N1)v
Status: Withdrawn
Authorisation Date: 2009-03-04
Therapeutic Area: Influenza, Human Disease Outbreaks Immunization
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

Prophylaxis of influenza caused by A(H1N1)v 2009 virus.

Celvapan should be used in accordance with official guidance.

The marketing authorisation for Celvapan has been withdrawn at the request of the marketing-authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide